Literature DB >> 11220514

Early intensive insulin treatment for induction of long-term glycaemic control in type 2 diabetes.

B Glaser1, E Cerasi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11220514     DOI: 10.1046/j.1463-1326.1999.00015.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  6 in total

1.  Effect of biphasic insulin aspart 30 combined with metformin on glycaemic control in obese people with type 2 diabetes.

Authors:  Belma Ascić-Buturović
Journal:  Bosn J Basic Med Sci       Date:  2007-11       Impact factor: 3.363

Review 2.  Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications.

Authors:  M Y Donath; P A Halban
Journal:  Diabetologia       Date:  2004-02-07       Impact factor: 10.122

3.  Glucose-responsive artificial promoter-mediated insulin gene transfer improves glucose control in diabetic mice.

Authors:  Jaeseok Han; Eung-Hwi Kim; Woohyuk Choi; Hee-Sook Jun
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

4.  Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment.

Authors:  Alfredo Halpern; Marcio C Mancini; Maria Eliane C Magalhães; Mauro Fisberg; Rosana Radominski; Marcelo C Bertolami; Adriana Bertolami; Maria Edna de Melo; Maria Teresa Zanella; Marcia S Queiroz; Marcia Nery
Journal:  Diabetol Metab Syndr       Date:  2010-08-18       Impact factor: 3.320

5.  Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study.

Authors:  Jochen Seufert; Katrin Pegelow; Peter Bramlage
Journal:  Vasc Health Risk Manag       Date:  2013-11-13

6.  Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes.

Authors:  Gyuri Kim; Yong Ho Lee; Eun Seok Kang; Bong Soo Cha; Hyun Chul Lee; Byung Wan Lee
Journal:  Yonsei Med J       Date:  2016-11       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.